XML 23 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2015
SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
 
 
A.
USE OF ESTIMATES:
 
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 
B.
FINANCIAL STATEMENTS IN U.S. DOLLARS:
 
The majority of the sales of InkSure Inc., our U.S. subsidiary, were made in U.S. dollars. In addition, a substantial portion of the U.S. subsidiary’s costs were incurred in U.S. dollars and the majority of the expenses of InkSure Ltd., the Israeli subsidiary, were paid in New Israeli Shekels, or NIS; however, most of the expenses were denominated and determined in U.S. dollars. The Company’s management believes that the U.S. dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the U.S. dollar.
 
Accordingly, monetary accounts maintained in currencies other than the dollar are re-measured into U.S. dollars in accordance with ASC Topic 830 “Foreign Currency Matters”. All transaction gains and losses of the re-measurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses, as appropriate.
 
 
C.
PRINCIPLES OF CONSOLIDATION:
 
The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany transactions and balances have been eliminated upon consolidation.
 
 
D.
CASH EQUIVALENTS:
 
Cash equivalents are short-term highly liquid investments purchased with maturities of three months or less as of the date acquired.
 
 
E.
REVENUE RECOGNITION:
 
The Company generated revenues mainly from sales of security inks and readers through a combination of its own sales personnel, strategic alliances and licenses with intermediaries.
 
Revenues from product sales were recognized in accordance with ASC Topic 605 “Revenue Recognition”, when delivery had occurred, persuasive evidence of an agreement existed, the vendor’s fee was fixed or determinable, no further obligation existed and collectability was probable. Delivery is considered to have occurred upon shipment of products. The Company did not grant a right of return to its customers.
 
Revenues from certain arrangements may include multiple elements within a single contract. The Company’s accounting policy complies with ASC Topic 605-25 “Multiple-Element Arrangements”, relating to the separation of multiple deliverables into individual accounting units with determinable fair value.
 
 
 
F.
WARRANTY:
 
The Company provided a warranty for its products. The term of the warranty was 12 months for hardware products and up to 18 months for TagSure products.
 
As of the balance sheet date, the Company did not receive any warranty claims and does not expect to receive any material warranty claims in the future. Therefore, the Company did not record a liability in respect of the warranty.
 
 
G.
RESEARCH AND DEVELOPMENT COSTS:
 
Research and development costs were charged to the statement of operations, as incurred.
 
 
H.
BASIC AND DILUTED NET PROFIT (LOSS) PER SHARE:
 
Basic and diluted net profit (loss) per share is presented in accordance with ASC Topic 260 “Earnings Per Share” for all periods presented. Basic and diluted net profit (loss) per share of common stock was determined by dividing net profit (loss) attributable to common stock holders by weighted average number of shares of common stock outstanding during the period. Diluted net loss per share of common stock is the same as basic net loss per share of common stock for fiscal year 2014 and 2015 presented as the effect of the Company’s potential additional shares of common stock were anti-dilutive.
 
All outstanding stock and options and warrants have been excluded from the calculation of the diluted net loss per share of common stock because all such securities are anti-dilutive for fiscal year 2014 and 2015. The total number of shares related to the outstanding options, warrants excluded from the calculations of diluted net loss per share were 2,153,433 for the year ended December 31, 2015 and 5,003,433 for the year ended December 31, 2014.
 
 
I.
INCOME TAXES:
 
The Company accounts for income taxes in accordance with ASC Topic 740 “Income Taxes”, which requires the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.
 
 
 
J.
CONCENTRATIONS OF CREDIT RISK:
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables.
 
Cash and cash equivalents are invested in major banks in Israel and the United States. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company’s investments are financially stable, and, accordingly, minimal credit risk exists with respect to these investments.
 
The trade receivables of the Company were mainly derived from sales to customers located in the United States and Europe. The Company performed credit evaluations of its customers and to date has not experienced any material losses. An allowance for doubtful accounts is determined with respect to those amounts that the Company has determined to be doubtful of collection. In certain circumstances, the Company required letters of credit, other collateral or additional guarantees.
 
 
K.
FAIR VALUE OF FINANCIAL INSTRUMENTS:
 
The carrying amounts reported in the balance sheet for cash and cash equivalents, trade receivables, and trade payables approximate their fair value due to the short-term maturities of such instruments.
 
 
L.
SHARE-BASED COMPENSATION:

The Company applies ASC Topic 718 “Compensation-Stock Compensation” requiring that compensation cost relating to share-based payment awards made to employees and directors be recognized in the financial statements. The principal awards issued under Company stock-based compensation plans include stock options. The cost for such awards is measured at the grant date based on the calculated fair value of the award. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods (generally the vesting period of the equity award) in the Company’s Consolidated Statement of Operations.

Compensation cost related to stock options is recognized in operating results (included in cost of revenues, research and development, selling and marketing, general and administrative expenses) under ASC Topic 718 which was an expense of $0 during 2015 and 2014, respectively.
 
The Company did not grant any new stock options in the years ended December 31, 2014 or 2015.
 
 
 
M.
FAIR VALUE MEASUREMENTS:
 
ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. The Topic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a fair value hierarchy that emphasizes use of observable inputs and minimizes use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
 
Level 1: Quoted prices in active markets for identical assets or liabilities.
 
Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
 
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.